安徽医科大学学报
安徽醫科大學學報
안휘의과대학학보
ACTA UNIVERSITY MEDICINALIS ANHUI
2015年
5期
625-627
,共3页
李涛%刘亚婷%闫川%徐元宏%周敏%肖春红%郝丽
李濤%劉亞婷%閆川%徐元宏%週敏%肖春紅%郝麗
리도%류아정%염천%서원굉%주민%초춘홍%학려
电化学发光法%癌胚抗原%偏倚
電化學髮光法%癌胚抗原%偏倚
전화학발광법%암배항원%편의
electrochemiluminescence immunoassay%carcinoma embryonic antigen%bias
目的:探讨电化学发光法(ECLIA)不同批号癌胚抗原(CEA)试剂室内质控发生明显偏倚时对患者检测结果的影响。方法留取两批次 CEA 试剂检测的标本数:批号为171617检测的临床标本66例;批号为172356检测的临床标本58例。用批号为172356 CEA 试剂重新检测,计算两次检测结果的偏倚。结果不同批号试剂检测结果差异有统计学意义(P =0.012);不同批号试剂检测结果偏倚与相同批号试剂检测结果偏倚两者比较差异有统计学意义( P <0.001);不同批号试剂检测结果正向偏倚和负向偏倚的比例与相同批号试剂检测结果正向偏倚和负向偏倚的比例,两者比较差异有统计学意义(P <0.001)。用室内质控的偏倚确定校正因子纠正患者结果,不同批号试剂纠正后结果差异没有统计学意义(P =0.828);不同批号试剂纠正后偏倚与相同批号试剂偏倚比较差异无统计学意义(P =0.092);不同批号试剂纠正后正向偏倚和负向偏倚的比例与相同批号试剂正向偏倚和负向偏倚的比例比较差异无统计学意义(P =0.774)。结论不同批号 CEA 试剂室内质控靶值存在明显偏倚时,患者检测结果会产生相似的偏倚,该偏倚可以通过校正因子进行纠正。
目的:探討電化學髮光法(ECLIA)不同批號癌胚抗原(CEA)試劑室內質控髮生明顯偏倚時對患者檢測結果的影響。方法留取兩批次 CEA 試劑檢測的標本數:批號為171617檢測的臨床標本66例;批號為172356檢測的臨床標本58例。用批號為172356 CEA 試劑重新檢測,計算兩次檢測結果的偏倚。結果不同批號試劑檢測結果差異有統計學意義(P =0.012);不同批號試劑檢測結果偏倚與相同批號試劑檢測結果偏倚兩者比較差異有統計學意義( P <0.001);不同批號試劑檢測結果正嚮偏倚和負嚮偏倚的比例與相同批號試劑檢測結果正嚮偏倚和負嚮偏倚的比例,兩者比較差異有統計學意義(P <0.001)。用室內質控的偏倚確定校正因子糾正患者結果,不同批號試劑糾正後結果差異沒有統計學意義(P =0.828);不同批號試劑糾正後偏倚與相同批號試劑偏倚比較差異無統計學意義(P =0.092);不同批號試劑糾正後正嚮偏倚和負嚮偏倚的比例與相同批號試劑正嚮偏倚和負嚮偏倚的比例比較差異無統計學意義(P =0.774)。結論不同批號 CEA 試劑室內質控靶值存在明顯偏倚時,患者檢測結果會產生相似的偏倚,該偏倚可以通過校正因子進行糾正。
목적:탐토전화학발광법(ECLIA)불동비호암배항원(CEA)시제실내질공발생명현편의시대환자검측결과적영향。방법류취량비차 CEA 시제검측적표본수:비호위171617검측적림상표본66례;비호위172356검측적림상표본58례。용비호위172356 CEA 시제중신검측,계산량차검측결과적편의。결과불동비호시제검측결과차이유통계학의의(P =0.012);불동비호시제검측결과편의여상동비호시제검측결과편의량자비교차이유통계학의의( P <0.001);불동비호시제검측결과정향편의화부향편의적비례여상동비호시제검측결과정향편의화부향편의적비례,량자비교차이유통계학의의(P <0.001)。용실내질공적편의학정교정인자규정환자결과,불동비호시제규정후결과차이몰유통계학의의(P =0.828);불동비호시제규정후편의여상동비호시제편의비교차이무통계학의의(P =0.092);불동비호시제규정후정향편의화부향편의적비례여상동비호시제정향편의화부향편의적비례비교차이무통계학의의(P =0.774)。결론불동비호 CEA 시제실내질공파치존재명현편의시,환자검측결과회산생상사적편의,해편의가이통과교정인자진행규정。
Objective To investigate the effect of different batches reagent of carcino-embryonic antigen by the electrochemiluminescence on the patients when internal quality control has obvious bias. Methods We measured samples from two batches of CEA clinical specimen, 66 from batch 171617 and 58 from batch 172356. All of these samples were re-measured by batch 172356, and then the bias of the two measures was analyzed. Results The de-tection results in different batches of reagent were of statistical significance (P = 0. 012). In result bias, there was a significant difference between the two groups (P < 0. 001). In the ratio of the positive and negative bias, there was also a significant difference between the two groups (P < 0. 001). There was no statistical significance (P =0. 828) in different batches of reagent following the adjustment of patients′ outcomes according to the bias of inter-nal quality control. There was no statistical significance (P = 0. 092) either after the adjustment in different batches of reagent compared with that of the same batch of the reagent. The proportions of the positive and the negative bias were of no statistical significance (P = 0. 774) compared with those of the same batch of reagent. Conclusion The patients′ outcomes would produce similar bias when the target value of CEA internal quality control detected by dif-ferent batches of reagents has significant bias and this bias can be adjusted by an adjustment factor.